These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6987071)

  • 1. Detection of human ADCC activity using automated flow cytometry.
    Attallah AM; Naguchi PD; Folks T; Noguchi CT
    Experientia; 1980 Jan; 36(1):124-5. PubMed ID: 6987071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibody-dependent cell-mediated cytotoxicity by automated flow cytometry. Comparison to a chromium release assay and characterization of the effector cell subpopulation.
    Attallah AM; Folks T; Noguchi PD; Noguchi T
    J Immunol Methods; 1980; 36(3-4):325-33. PubMed ID: 7000911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
    J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies.
    Schnueriger A; Grau R; Sondermann P; Schreitmueller T; Marti S; Zocher M
    Mol Immunol; 2011 Jul; 48(12-13):1512-7. PubMed ID: 21570725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.
    Richard J; Veillette M; Batraville LA; Coutu M; Chapleau JP; Bonsignori M; Bernard N; Tremblay C; Roger M; Kaufmann DE; Finzi A
    J Virol Methods; 2014 Nov; 208():107-14. PubMed ID: 25125129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitating ADCC against adherent cells: Impedance-based detection is superior to release, membrane permeability, or caspase activation assays in resolving antibody dose response.
    Tóth G; Szöllősi J; Vereb G
    Cytometry A; 2017 Oct; 91(10):1021-1029. PubMed ID: 28945315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays.
    Chung S; Nguyen V; Lin YL; Kamen L; Song A
    J Immunol Methods; 2017 Aug; 447():37-46. PubMed ID: 28434980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
    Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
    J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
    Chung S; Lin YL; Reed C; Ng C; Cheng ZJ; Malavasi F; Yang J; Quarmby V; Song A
    J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC).
    Nelson DL; Kurman CC; Serbousek DE
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.27. PubMed ID: 18432838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.
    Kramski M; Schorcht A; Johnston AP; Lichtfuss GF; Jegaskanda S; De Rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ
    J Immunol Methods; 2012 Oct; 384(1-2):51-61. PubMed ID: 22841577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flow cytometry-based assay for the evaluation of antibody-dependent cell-mediated cytotoxicity (ADCC) in cancer cells.
    Salinas-Jazmín N; Hisaki-Itaya E; Velasco-Velázquez MA
    Methods Mol Biol; 2014; 1165():241-52. PubMed ID: 24839029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate CD16-expressing effector cell lines for determining the bioactivity of therapeutic monoclonal antibodies.
    Gurjar SA; Derrick JP; Dearman RJ; Thorpe R; Hufton S; Kimber I; Wadhwa M
    J Pharm Biomed Anal; 2017 Sep; 143():188-198. PubMed ID: 28605680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.